GSK Investigational Site

Sibu 96000

0 studies enrolling now · 4 studies all time

What they study most

Arthritis, Rheumatoid, Asthma, Measles, Measles-Mumps-Rubella Vaccine, Mumps, Pulmonary Disease, Chronic Obstructive, Rubella

Studies at this site

• Long-term Safety and Efficacy of GSK3196165 (Otilimab) in the Treatment of Rheumatoid Arthritis (RA) — Stopped early
• Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Combined Measles-mumps-rubella (MMR) Vaccine in Children in Their Second Year of Life — Completed
• Study to Evaluate the Effect of Fluticasone Furoate/Vilanterol on Survival in Subjects With Chronic Obstructive Pulmonary Disease — Completed
• 6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old — Completed